Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The orexin receptor OX1R in colon cancer: a promising therapeutic target and a new paradigm in G protein‐coupled receptor signalling through ITIMs
Marc Laburthe, Thierry Voisin
British Journal of Pharmacology (2011) Vol. 165, Iss. 6, pp. 1678-1687
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
S P H Alexander, Helen E. Benson, Elena Faccenda, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 8, pp. 1459-1581
Open Access | Times Cited: 552
Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders
Tian‐Rui Xu, Yang Yang, Richard J. Ward, et al.
Cellular Signalling (2013) Vol. 25, Iss. 12, pp. 2413-2423
Closed Access | Times Cited: 142
Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A
Richard J. Ward, John D. Pediani, Graeme Milligan
Journal of Biological Chemistry (2011) Vol. 286, Iss. 43, pp. 37414-37428
Open Access | Times Cited: 91
Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice
Anne Blais, Gaëtan Drouin, Catherine Chaumontet, et al.
PLoS ONE (2017) Vol. 12, Iss. 1, pp. e0169908-e0169908
Open Access | Times Cited: 39
Using the fragment molecular orbital method to investigate agonist–orexin-2 receptor interactions
Alexander Heifetz, Matteo Aldeghi, Ewa I. Chudyk, et al.
Biochemical Society Transactions (2016) Vol. 44, Iss. 2, pp. 574-581
Open Access | Times Cited: 32
The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role
Alain Couvineau, Stéphanie Dayot, Pascal Nicole, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 32
The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosis
David Alexandre, Coralie Hautot, Marwa Mehio, et al.
European Journal of Cancer (2014) Vol. 50, Iss. 12, pp. 2126-2133
Closed Access | Times Cited: 34
Dual-agonist occupancy of orexin receptor 1 and cholecystokinin A receptor heterodimers decreases G-protein–dependent signaling and migration in the human colon cancer cell line HT-29
Bo Bai, Xiaoyu Chen, Rumin Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2017) Vol. 1864, Iss. 7, pp. 1153-1164
Open Access | Times Cited: 28
Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders
Hiroshi Tsuneki, Tsutomu Wada, Toshiyasu Sasaoka
Pharmacology & Therapeutics (2017) Vol. 186, pp. 25-44
Closed Access | Times Cited: 28
Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A
Nassima Messal, Neïké Fernandez, Stéphanie Dayot, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 11, pp. 3618-3628
Closed Access | Times Cited: 27
Comparative Network Analysis of Patients with Non-Small Cell Lung Cancer and Smokers for Representing Potential Therapeutic Targets
Mehrdad Pazhouhandeh, Fatemeh Samiee, Tahereh Boniadi, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 25
In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
Stéphanie Dayot, Daniela Speisky, Anne Couvelard, et al.
Oncotarget (2018) Vol. 9, Iss. 6, pp. 6952-6967
Open Access | Times Cited: 25
Orexin A Suppresses the Expression of Exosomal PD-L1 in Colon Cancer and Promotes T Cell Activity by Inhibiting JAK2/STAT3 Signaling Pathway
Jing Wen, Xiaocen Chang, Bowen Bai, et al.
Digestive Diseases and Sciences (2021) Vol. 67, Iss. 6, pp. 2173-2181
Closed Access | Times Cited: 18
Orexins in apoptosis: a dual regulatory role
Simona Cavalu, Sameh Saber, Rabab S. Hamad, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Modeling of the OX1R–orexin-A complex suggests two alternative binding modes
Lasse Karhu, Ainoleena Turku, Henri Xhaard
BMC Structural Biology (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Azulene-based compounds for targeting orexin receptors
Teppo O. Leino, Ainoleena Turku, Jari Yli‐Kauhaluoma, et al.
European Journal of Medicinal Chemistry (2018) Vol. 157, pp. 88-100
Closed Access | Times Cited: 21
Crucial role of the orexin‐B C‐terminus in the induction of OX1 receptor‐mediated apoptosis: analysis by alanine scanning, molecular modelling and site‐directed mutagenesis
Pascal Nicole, Pierre Couvineau, Nadège Jamin, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 21, pp. 5211-5223
Open Access | Times Cited: 20
Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands
Ainoleena Turku, Alexandre Borrel, Teppo O. Leino, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 18, pp. 8263-8275
Closed Access | Times Cited: 19
Effects of Vestibular Damage on the Sleep and Expression Level of Orexin in the Hypothalamus of Rats and Its Correlation with Autophagy and Akt Tumor Signal Pathway
Gangli Yan, Fengguang Li, Zhiwei Tao, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 10
Original Research: Orexins A and B stimulate proliferation and differentiation of porcine preadipocytes
Tatiana Wojciechowicz, Marek Skrzypski, Dawid Szczepankiewicz, et al.
Experimental Biology and Medicine (2016) Vol. 241, Iss. 16, pp. 1786-1795
Open Access | Times Cited: 17
A review of orexin’s unprecedented potential as a novel, highly-specific treatment for various localized and metastatic cancers
Nicole L Graybill, Volkmar Weissig
SAGE Open Medicine (2017) Vol. 5
Open Access | Times Cited: 17
Involvement of the Orexinergic System in Cancer: Antitumor Strategies and Future Perspectives
Pilar Marcos, Rafael Coveñas
Applied Sciences (2023) Vol. 13, Iss. 13, pp. 7596-7596
Open Access | Times Cited: 5
Machine Learning Models to Predict Ligand Binding Affinity for the Orexin 1 Receptor
Vanessa Zhang, Shayna L. O’Connor, William J. Welsh, et al.
Artificial Intelligence Chemistry (2023) Vol. 2, Iss. 1, pp. 100040-100040
Open Access | Times Cited: 4
Determinants of Orexin Receptor Binding and Activation—A Molecular Dynamics Study
Lasse Karhu, Aniket Magarkar, Alex Bunker, et al.
The Journal of Physical Chemistry B (2019) Vol. 123, Iss. 12, pp. 2609-2622
Open Access | Times Cited: 11
Orexin receptors: Targets and applications
Subhiksha Subramanian, Mirunalini Ravichandran
Fundamental and Clinical Pharmacology (2021) Vol. 36, Iss. 1, pp. 72-80
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top